Not Only Enteropathy: The Overlooked “Gastric Side” of Olmesartan

Clinical Case Reports 2026 Open access

Read full text
Authors: Cecilia Lina Pugliano, Stefania Piccirelli, Denise Bianchi, Clarissa Ferrari, Cristiano Spada, Paola Cesaro
DOI: 10.1002/ccr3.70845
Cited by: 1
References: 14

Abstract

Several medications can be associated with gastrointestinal adverse effects. Olmesartan has been linked to a broad spectrum of gastrointestinal injuries. Although sprue-like enteropathy is well known, less common involvements such as gastropathy can be equally debilitating. Differential diagnosis can be challenging in individual cases, but in our patient, drug withdrawal led to complete recovery.

Fields of Study & Subjects

Celiac Disease Research and Management Microscopic Colitis Lymphatic Disorders and Treatments

Publication details

Journal / source
Clinical Case Reports
Publisher
Wiley
Volume
14
Issue
5
Pages
e70845–e70845
Publication date
1 May 2026
Language
EN